Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery
Status:
Unknown status
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
To study post-operative efficacy of Exparel® for pain control in patients undergoing any
Urogynecology surgery involving the posterior vaginal wall using a randomized, double-blinded
placebo controlled trial.